Evidence map›Paper›PMID 38315236›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2024

Dosimetric advantages for cardiac substructures in radiotherapy of esophageal cancer in deep-inspiration breath hold.

Ahmed Allam Mohamed, Melina Nausikaa Douglas, Philipp Bruners, Michael J Eble

Abstract read
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ahmed Allam MohamedDepartment of Radiation Oncology, RWTH Aachen University Hospital, Pauwelstr. 30, 52074, Aachen, Germany. amohamed@ukaachen.de.ORCID 0000-0002-0978-1996
Melina Nausikaa DouglasDepartment of Radiation Oncology, RWTH Aachen University Hospital, Pauwelstr. 30, 52074, Aachen, Germany.
Philipp BrunersDepartment of Diagnostic and Interventional Radiology, RWTH Aachen University Hospital, Aachen, Germany.
Michael J EbleDepartment of Radiation Oncology, RWTH Aachen University Hospital, Pauwelstr. 30, 52074, Aachen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadiotherapy is one of the main treatment options for patients with esophageal cancer; however, it has been linked with an increased risk of cardiac toxicities. In the current study, we evaluated the effect of planning the radiation in deep-inspiration breath hold (DIBH) on the dose sparing of cardiac substructures and lung. MATERIALS AND

methodsIn this study, we analyzed 30 radiation therapy plans from 15 patients diagnosed with esophageal cancer planned for neoadjuvant radiotherapy. Radiation plans were generated for 41.4 Gy and delivered in 1.8 Gy per fraction for free-breathing (FB) and DIBH techniques. We then conducted a comparative dosimetric analysis, evaluating target volume coverage, the impact on cardiac substructures, and lung doses across the two planning techniques for each patient.

resultsThere was no significant disparity in target volume dose coverage between DIBH and FB plans. However, the D

conclusionRadiotherapy in DIBH could provide a method to reduce the radiation dose to the left ventricle and coronaries, which could reduce the cardiac toxicity of the modality.

Indexed as

Breath HoldingEsophageal NeoplasmsHeartRadiotherapy DosageRadiotherapy Planning, Computer-AssistedAgedFemaleHumansMaleMiddle AgedNeoadjuvant TherapyOrgans at RiskRadiation InjuriesRadiometryCardiac toxicityChemoradiotherapyCROSS protocolNeoadjuvantPulmonary toxicity

Identifiers

PMID38315236
PMCPMC11186874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.